Who is sponsoring NCT06284083?

NCT06284083 is sponsored by Cumhuriyet University.

What drugs are being tested in NCT06284083?

Interventions in NCT06284083: taking a blood sample.

What condition does NCT06284083 study?

NCT06284083 studies Obstructive Sleep Apnea-hypopnea Syndrome.

Is NCT06284083 still recruiting?

NCT06284083 is currently completed. Last updated 28 February 2024.

Last reviewed 2024-02-28 · How we verify

NCT06284083: OUAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measuring Various Variables in Obstructive Sleep Apnea

Completed NA Last updated 28 February 2024

What this trial tests

NA trial testing taking a blood sample in Obstructive Sleep Apnea-hypopnea Syndrome in 90 participants. Completed in 7 February 2022.

Timeline

18 December 2018

Primary endpoint
15 January 2021

7 February 2022

Quick facts

Lead sponsor	Cumhuriyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	90
Start date	18 December 2018
Primary completion	15 January 2021
Estimated completion	7 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

taking a blood sample

Conditions studied

Obstructive Sleep Apnea-hypopnea Syndrome — all drugs for Obstructive Sleep Apnea-hypopnea Syndrome →

Sponsor

Cumhuriyet University

Who can join

Adults 18 to 74, any sex, with Obstructive Sleep Apnea-hypopnea Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study included 90 volunteer Obstructive Sleep Apnea Syndrome patients. Only 7 mL blood samples collected from patients. Some biochemicals parameters analyzed in blood serum/plasma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of taking a blood sample

Trials testing the same drug.

NCT05343273 — 25-Hydroxyvitamin D Levels in Patients With Periodontitis (Stage III) · completed

Other Cumhuriyet University trials

Trials by the same sponsor.

NCT07289425 — Effect of a Mobile App for Obese Children on Eating Attitudes, Eating Awareness, and Healthy Eating Self-Efficacy · NA · not yet recruiting
NCT07482735 — Effect of Perturbation Exercise Protocol in Patients With Partial Rotator Cuff Tear: A Single-Blind Randomized Controlle · NA · active not recruiting
NCT07446699 — The Effect of Pushing Techniques Used During Childbirth on Women's Labor Duration, Pain, and Fatigue Levels · NA · active not recruiting
NCT07298681 — The Effect of Benner's Jigsaw Teaching Technique Based on the Novice to Expert Model and Scenario-Based Peripheral Intra · NA · recruiting
NCT07474402 — The Effect of a Multi-Component Breastfeeding Support Program on Breastfeeding Self-Efficacy and Mother-Infant Bonding i · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06284083 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cumhuriyet University
Last refreshed: 28 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06284083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing